Wednesday 6 February 2019

Stealth Research: Lack of peer-reviewed evidence from healthcare unicorns (2019)

A stimulating paper for anyone who works in, or works with, a bio-medical start-up company. The author's summary of their paper is as follows:

  • Start-ups are widely accepted as key vehicles of innovation and disruption in healthcare, positioned to make revolutionary discoveries.
  • Most of the highest valued start-ups in healthcare have a limited or non-existent participation and impact in the publicly available scientific literature.
  • The system of peer-reviewed publishing, while imperfect, is indispensable for validating innovative products and technologies in biomedicine.
  • Healthcare products not subjected to peer-review but rather based on internal data generation alone may be problematic and non-trustworthy.